The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study
Authors:
- Denis XavierDXDenis Xavier
- on behalf of The Indian Polycap Study (TIPS) InvestigatorsOIon behalf of The Indian Polycap Study (TIPS) Investigators
- 23 December 2008
- journal article
- research article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 6 (2) , 96-97
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry dataThe Lancet, 2008
- Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisBMJ, 2003
- Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ, 2003
- A strategy to reduce cardiovascular disease by more than 80%BMJ, 2003
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialThe Lancet, 2003
- Heart Protection StudyThe Lancet, 2003
- Two decades of progress in preventing vascular diseaseThe Lancet, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002